|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,255.00 JPY | +0.11% |
|
+1.68% | +8.69% |
| 02:44pm | Takeda Pharmaceutical Reportedly Found Liable in Constipation Drug Antitrust Case | MT |
| 07:36am | US Jury Orders Takeda to Pay $885 Million in AMITIZA Antitrust Case; Takeda Plans Appeal | MT |
| Capitalization | 8,29300Cr 5.22TCr 4.48TCr 4.1TCr 3.9TCr 7.18TCr 5,02800Cr 7.3TCr 49TCr 19TCr 2,37900Cr 20TCr 19TCr | P/E ratio 2026 |
46.4x | P/E ratio 2027 * | 38.4x |
|---|---|---|---|---|---|
| Enterprise value | 12,23200Cr 7.7TCr 6.62TCr 6.05TCr 5.75TCr 11TCr 7,41700Cr 11TCr 72TCr 28TCr 3,50900Cr 29TCr 28TCr | EV / Sales 2026 |
1.99x | EV / Sales 2027 * | 2.62x |
| Free-Float |
99.25% | Yield 2026 * |
3.81% | Yield 2027 * | 3.89% |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 day | +0.11% | ||
| 1 week | +1.68% | ||
| Current month | -0.28% | ||
| 1 month | -5.74% | ||
| 3 months | -9.63% | ||
| 6 months | +19.16% | ||
| Current year | +8.69% |
| 1 week | 5,039 |  | 5,352 |
| 1 month | 5,039 | | 5,626 |
| Current year | 4,863 | | 6,033 |
| 1 year | 4,086 | | 6,033 |
| 3 years | 3,852 | | 6,033 |
| 5 years | 2,993 | | 6,033 |
| 10 years | 2,894.5 | | 6,693 |
| Manager | Title | Age | Since |
|---|---|---|---|
Christophe Weber
CEO | Chief Executive Officer | 59 | 01/04/2015 |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 01/04/2024 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 47 | 01/02/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Christophe Weber
BRD | Director/Board Member | 59 | 01/06/2014 |
Andrew Plump
BRD | Director/Board Member | 60 | 01/06/2015 |
| Director/Board Member | 74 | 01/06/2016 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +12.95% | 3.26% | 118 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.11% | +1.68% | +28.20% | +17.56% | 5.22TCr | |
| -1.67% | +2.18% | +30.46% | +125.65% | 88TCr | |
| +0.97% | +3.38% | +51.27% | +44.45% | 55TCr | |
| -0.47% | +3.27% | +13.80% | +45.99% | 37TCr | |
| +1.36% | +1.06% | +24.30% | +13.90% | 33TCr | |
| +1.08% | +2.21% | +29.39% | +30.88% | 28TCr | |
| +0.62% | +0.26% | +32.90% | +14.77% | 28TCr | |
| +1.06% | +1.15% | +47.99% | -1.26% | 28TCr | |
| -0.10% | -4.74% | -35.62% | -52.12% | 20TCr | |
| -0.59% | -1.58% | +19.08% | +44.67% | 18TCr | |
| Average | +0.38% | +1.12% | +24.18% | +28.45% | 34.01TCr | |
| Weighted average by Cap. | +0.32% | +1.69% | +28.52% | +49.35% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 4,53100Cr 2.85TCr 2.45TCr 2.24TCr 2.13TCr 3.92TCr 2,74800Cr 3.99TCr 27TCr 10TCr 1,30000Cr 11TCr 10TCr | 4,61500Cr 2.9TCr 2.5TCr 2.28TCr 2.17TCr 3.99TCr 2,79800Cr 4.06TCr 27TCr 11TCr 1,32400Cr 11TCr 11TCr |
| Net income | 17TCr 109.82Cr 94Cr 86Cr 82Cr 150.96Cr 11TCr 153.54Cr 1.03TCr 400.48Cr 5.01TCr 412.15Cr 403.42Cr | 21TCr 130.78Cr 112.36Cr 102.81Cr 98Cr 179.77Cr 13TCr 182.84Cr 1.23TCr 476.9Cr 5.96TCr 490.8Cr 480.41Cr |
| Net Debt | 3,94000Cr 2.48TCr 2.13TCr 1.95TCr 1.85TCr 3.41TCr 2,38900Cr 3.47TCr 23TCr 9.04TCr 1,13000Cr 9.31TCr 9.11TCr | 3,79700Cr 2.39TCr 2.05TCr 1.88TCr 1.78TCr 3.29TCr 2,30300Cr 3.34TCr 22TCr 8.72TCr 1,08900Cr 8.97TCr 8.78TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/26/19 | 5,255.00 ¥ | +0.11% | 44,14,600 |
| 18/26/18 | 5,249.00 ¥ | -0.53% | 33,72,900 |
| 15/26/15 | 5,277.00 ¥ | +0.40% | 52,58,600 |
| 14/26/14 | 5,256.00 ¥ | +1.23% | 54,53,200 |
| 13/26/13 | 5,192.00 ¥ | +0.46% | 38,87,700 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4502 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition